trial

Treatment of Social Cognition in Schizophrenia Trial

NCTId NCT02246426
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 149 (actual)
Sponsored by Posit Science Corporation
Primary completion 2018-08-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
149 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2015-03
Primary completion
2018-08-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Computerized plasticity-based adaptive cognitive trainingCommercially available computerized training

Sponsors

Posit Science CorporationLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
University of MinnesotaCollaborator
VA Greater Los Angeles Healthcare SystemCollaborator
University of California Riverside at C.I. Trials, Inc.-Inland EmpireCollaborator
Rush University Medical CenterCollaborator

Investigators

1
Kyu Lee, PhDPrincipal Investigator

Sites

4 total
Los Angeles, United StatesLos Angeles, United StatesChicago, United StatesMinneapolis, United States

Facts & assertions

4 sourced
Enrollment
149
Phase
NA
Primary Completion Date
2018-08-30
Status
COMPLETED
relationships
The graph out of here
drug
Computerized plasticity-based adaptive cognitive training
drug
Commercially available computerized training
drug
lead_sponsor
Posit Science Corporation
company
collaborator
National Institute of Mental Health (NIMH)
company
University of Minnesota
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Kyu Lee, PhD
person